These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 18310106)
1. Approaches to dimensionality reduction in proteomic biomarker studies. Hilario M; Kalousis A Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery. Fang X; Balgley BM; Lee CS Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464 [TBL] [Abstract][Full Text] [Related]
3. Processing and classification of protein mass spectra. Hilario M; Kalousis A; Pellegrini C; Müller M Mass Spectrom Rev; 2006; 25(3):409-49. PubMed ID: 16463283 [TBL] [Abstract][Full Text] [Related]
4. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research. Ekegren T; Hanrieder J; Bergquist J J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436 [TBL] [Abstract][Full Text] [Related]
5. Proteomic approaches in biological and medical sciences: principles and applications. Conrotto P; Souchelnytskyi S Exp Oncol; 2008 Sep; 30(3):171-80. PubMed ID: 18806738 [TBL] [Abstract][Full Text] [Related]
6. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia. Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325 [TBL] [Abstract][Full Text] [Related]
7. Alignment of LC-MS images, with applications to biomarker discovery and protein identification. Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649 [TBL] [Abstract][Full Text] [Related]
8. Protein mass spectra data analysis for clinical biomarker discovery: a global review. Roy P; Truntzer C; Maucort-Boulch D; Jouve T; Molinari N Brief Bioinform; 2011 Mar; 12(2):176-86. PubMed ID: 20534688 [TBL] [Abstract][Full Text] [Related]
9. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery. deVera IE; Katz JE; Agus DB Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241 [TBL] [Abstract][Full Text] [Related]
10. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry. Ahmed FE J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839 [TBL] [Abstract][Full Text] [Related]
19. Classification of peptide mass fingerprint data by novel no-regret boosting method. Gambin A; Szczurek E; Dutkowski J; Bakun M; Dadlez M Comput Biol Med; 2009 May; 39(5):460-73. PubMed ID: 19386298 [TBL] [Abstract][Full Text] [Related]
20. Utility of mass spectrometry for proteome analysis: part II. Ion-activation methods, statistics, bioinformatics and annotation. Ahmed FE Expert Rev Proteomics; 2009 Apr; 6(2):171-97. PubMed ID: 19385944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]